BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1093384)

  • 1. Hemophilia and von Willebrand's disease. Some biological determinants. H. P. Smith memorial lecture.
    Brinkhous KM
    Am J Clin Pathol; 1975 May; 63(5):609-17. PubMed ID: 1093384
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH; Ekert H; Helliger H
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
    Barbui T; Battista R; Dini E
    Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factor VIII in hemophilia and von Willebrand's disease].
    Bolland J; Lambotte C
    Rev Med Liege; 1978 Apr; 33(8):284-95. PubMed ID: 349657
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Enhanced factor VIII activity in von Willebrand's disease.
    Mannucci PM; Pareti FI; Ruggeri ZM
    N Engl J Med; 1974 May; 290(22):1259. PubMed ID: 4545219
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture.
    West J Med; 1974 Mar; 120(3):226-32. PubMed ID: 4544608
    [No Abstract]   [Full Text] [Related]  

  • 18. The von Willebrand syndrome.
    Stableforth P; Hughes J; Wilson E; Dormandy KM
    Br J Haematol; 1975 Apr; 29(4):605-16. PubMed ID: 1081404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine von Willebrand's disease.
    Dodds WJ
    J Lab Clin Med; 1970 Nov; 76(5):713-21. PubMed ID: 5312238
    [No Abstract]   [Full Text] [Related]  

  • 20. On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease.
    Egberg N; Blombäck M
    Thromb Res; 1976 Nov; 9(5):527-31. PubMed ID: 1087055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.